4//SEC Filing
Wai Conrad 4
Accession 0001801170-24-000192
CIK 0001801170other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:07 PM ET
Size
9.0 KB
Accession
0001801170-24-000192
Insider Transaction Report
Form 4
Wai Conrad
CEO, Counterpart Health
Transactions
- Award
Class A Common Stock
2024-09-13+189,934→ 3,043,529 total - Tax Payment
Class A Common Stock
2024-09-13$2.99/sh−93,180$278,608→ 2,950,349 total - Tax Payment
Class A Common Stock
2024-09-14$2.99/sh−98,217$293,669→ 2,852,132 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date.
- [F2]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above.
- [F3]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001971702
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:07 PM ET
- Size
- 9.0 KB